IoM Drug Safety Meeting Will Hear Remarks By House Anti-Narcotics Staffer
This article was originally published in The Pink Sheet Daily
Executive Summary
The Institute of Medicine’s second meeting on the U.S. drug safety system will also include presentations from FDA, CMS and AHRQ on their role in drug safety. Other scheduled speakers include a series of consumer representatives.
You may also be interested in...
Pharma Companies Will Not Present At Second IoM Drug Review Meeting
No pharmaceutical industry representatives are scheduled to speak during the open public forum of the July 19-20 IoM drug safety review meeting
Pharma Companies Will Not Present At Second IoM Drug Review Meeting
No pharmaceutical industry representatives are scheduled to speak during the open public forum of the July 19-20 IoM drug safety review meeting
IoM Drug Safety Committee Meeting
The Institute of Medicine committee charged with reviewing the drug safety system will hold its second meeting July 19-20